Show simple item record

dc.contributor.authorOnyango, Elizabeth O
dc.contributor.authorAyodo, George
dc.contributor.authorWatsierah, Carren A
dc.contributor.authorWere, Tom
dc.contributor.authorOkumu, Wilson
dc.contributor.authorAnyona, Samuel B
dc.contributor.authorRaballah, Evans
dc.contributor.authorOkoth, John M
dc.contributor.authorGumo, Sussy
dc.contributor.authorOrinda, George O
dc.contributor.authorOuma, Collins
dc.date.accessioned2021-05-31T08:17:14Z
dc.date.available2021-05-31T08:17:14Z
dc.date.issued2012-06-24
dc.identifier.urihttps://doi.org10.1186/1471-2334-12-143
dc.identifier.urihttps://pubmed.ncbi.nlm.nih.gov/22726955/
dc.identifier.urihttp://r-library.mmust.ac.ke/123456789/1534
dc.description.abstractBackground: Over the years, reports implicate improper anti-malarial use as a major contributor of morbidity and mortality amongst millions of residents in malaria endemic areas, Kenya included. However, there are limited reports on improper use of Artemisinin-based Combination Therapy (ACT) which is a first-line drug in the treatment of malaria in Kenya. Knowing this is important for ensured sustainable cure rates and also protection against the emergence of resistant malarial parasites. We therefore investigated ACT adherence level, factors associated with non-adherence and accessibility in households (n = 297) in rural location of Southeast Alego location in Siaya County in western Kenya. Methods: ACT Adherence level was assessed with reference to the duration of treatment and number of tablets taken. Using systematic random sampling technique, a questionnaire was administered to a particular household member who had the most recent malaria episode (<2 weeks) and used ACT for cure. Parents/caretakers provided information for children aged <13 years. Key Informant Interviews (KIIs) were also conducted with healthcare providers and private dispensing chemist operators. Results: Adherence to ACT prescription remained low at 42.1% and 57.9% among individuals above 13 and less than 13 years, respectively. Stratification by demographic and socio-economic characteristics in relation to ACT adherence revealed that age (P = 0.011), education level (P < 0.01), ability to read (P < 0.01) and household (HH) monthly income (P = 0.002) significantly affected the level of ACT adherence. Consistently, logistic regression model demonstrated that low age (OR, 0.571, 95% CI, 0.360-0.905; P = 0.017), higher education level (OR, 0.074; 95% CI 0.017-0.322; P < 0.01), ability to read (OR, 0.285, 95% CI, 0.167-0.486; P < 0.01) and higher income (Ksh. > 9000; OR, 0.340; 95% CI, 0.167-0.694; P = 0.003) were associated with ACT adherence. In addition, about 52.9% of the respondents reported that ACT was not always available at the source and that drug availability (P = 0.020) and distance to drug source (P < 0.01) significantly affected accessibility. Conclusions: This study demonstrates that more than half of those who get ACT prescription do not take recommended dose and that accessibility is of concern. Theen_US
dc.language.isoenen_US
dc.publisherNational Library of Medicineen_US
dc.subjectnon-adherence, Artemisinin-based,combination therapy, malaria, population,en_US
dc.titleFactors associated with non-adherence to Artemisinin-based combination therapy (ACT) to malaria in a rural population from holoendemic region of western Kenyaen_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record